Home > Healthcare > Medical Devices > Diagnostic Devices > Capsule Endoscopy Market

Capsule Endoscopy Market Trends

Report ID: GMI5928
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Capsule Endoscopy Market Trends

Increasing prevalence of GI disorders and other chronic ailments has augmented the market growth. The prevalence of GI disorders such as colorectal cancer, Crohn's disease, celiac disease, and gastrointestinal bleeding has been on the rise globally. For instance, according to the European Crohn's and Colitis Organisation (ECCO) data, in 2020, around 2.5 million people in Europe were affected by IBD and is expected to increase in the coming years. These conditions often require thorough examination and evaluation of the GI tract, making capsule endoscopy an effective and minimally invasive diagnostic tool.

Additionally, ageing population has increased likelihood of developing chronic diseases, including GI disorders and more susceptible to conditions like colorectal cancer and gastrointestinal bleeding. Capsule endoscopy provides a valuable diagnostic solution for this population, as it is less invasive and better tolerated by older patients.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for capsule endoscopy was valued at over USD 682.5 million in 2022 and will reach over USD 1,694.4 million in 2032, owing to increasing prevalence of gastrointestinal disorders (GI), cancer and other chronic ailments, along with patient preference for minimally invasive procedures.

Market size from obscure gastrointestinal bleeding (OGIB) application will reach USD 744.7 million by 2032, due to rising prevalence of gastrointestinal bleeding among adult and geriatric population base which is increasing the adoption of capsule endoscopes.

North America capsule endoscopy market will grow at 8.9% CAGR by 2032. The growth is ascribed to a variety of factors, including the presence of significant industry players, an increase in the number of patients suffering from GI disorders, and expanding elderly population.

Anx Robotica, CapsoVision Inc., Check-Cap Ltd., Chongqing Jinshan Science and Technology Group Co., Fujifilm Holding Corporation, IntroMedic Co., Medtronic plc, Olympus Corporation, RF System lab and Shangxian Minimal Invasive Inc. among others.